Abatacept in Double Cord Blood Unit Transplant
ABBA CORD: Double Umbilical Cord Blood Transplants With Abatacept for Graft Versus Host Disease Prophylaxis
More Information
- Trial Status
- Not yet accepting
- Trial Phase
- Phase 2
- Enrollment
- 20 patients (estimated)
- Sponsors
- Case Comprehensive Cancer Center
- Tags
- Immunomodulatory Drug (IMiD), T Cell
- Trial Type
- Supportive
- Last Update
- 2 weeks ago
- SparkCures ID
- 2019
- NCT Identifier
- NCT06680661
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.